Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis

Authors:

Abstract
Background: Traditional and non-traditional cardiovascular (CV) risk factors underlie CV disease occurrence in rheumatoid arthritis (RA). Recently, a functional impairment of HDL has been observed. Although the actual players are unknown, anti-HDL were associated with altered lipid profile, decreased paraoxonase 1 (PON1) activity and CV disease in RA. Therefore, we aimed to evaluate whether the presence of antibodies against PON1 may be involved in this scenario. Methods: IgG anti-PON1 antibodies were quantified by ELISA in serum samples from 212 RA patients, 175 healthy controls (HC), and 54 subjects with traditional CV risk factors. A subgroup of 13 RA patients was prospectively followed upon TNFα-blockade. Serum PON1 activity, NO and total antioxidant capacity (TAC) were measured. IFNγ, IL-8, MCP-1, VEGF, sICAM and TNFα serum levels were assessed by immunoassays. PON1 rs662 (Q>R) status was studied by RT-PCR. Results: IgG anti-PON1 antibodies are increased in RA patients compared to HC (p Conclusions: anti-PON1 antibodies can be responsible of PON1 impairment in RA patients, with a potential impact on biomarkers of oxidative status and endothelial activation. A gene-environment interaction of rs662 variants is supported.

This publication has 56 references indexed in Scilit: